Aligos Therapeutics Announces Acceptance of Abstracts on Incremental Data from ALG-000184 in CHB Subjects and Late-Breaker Oral Presentation of Data from the Phase 2a HERALD Study of ALG-055009 in MASH Subjects at The Liver Meeting (TLM) 2024

Saved in:
Bibliographic Details
Published inNews Bites US - NASDAQ
Format Newsletter
LanguageEnglish
Published Melbourne News Bites Pty Ltd 16.10.2024
Subjects
Gastroenterology
Hepatitis B
Hepatology
Liver
Metabolism
Thyroid gland
United States > US
Online AccessGet full text

Cover

More Information
Description not available.